Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use

INTRODUCTION: HIV-infected individuals have evidence of intestinal microbial translocation which is associated with immune activation and unfavorable clinical outcomes. Rifaximin, a non-absorbable antibiotic which reduces microbial translocation in other disease states, was shown to have a marginal...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Brett B., Green, Stefan J., Bosch, Ronald J., Chan, Ellen S., Jacobson, Jeffrey M., Margolis, David M., Engen, Phillip, Landay, Alan L., Wilson, Cara C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768152/
https://www.ncbi.nlm.nih.gov/pubmed/31583331
http://dx.doi.org/10.20411/pai.v4i2.290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768152/
https://www.ncbi.nlm.nih.gov/pubmed/31583331
http://dx.doi.org/10.20411/pai.v4i2.290

Ejemplares similares